Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
2022, NEJM) showed 20.9 percent weight loss at 72 weeks, the primary clinical reference OptumRx uses when evaluating medical necessity
Click or tap Get free coupon to generate a reusable SingleCare prescription discount card
Your provider will order blood tests to check your thyroid function and hormone levels
Incretin-based drugs are a class of glucose-lowering therapies that mimic or enhance the action of natural incretin hormones, primarily GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), to improve insulin secretion, suppress glucagon release, slow gastric emptying, and support weight loss in patients with type 2 diabetes and obesity
US$ 25.47
US$ 25.50
US$ 21.42
US$ 27.03
US$ 21.62
US$ 24.31
US$ 26.40
